About
TAZ Inc. is a Tokyo-based University of Tokyo spinout biotech company developing longevity and anti-aging technologies. The company screens for calorie restriction–mimetic and senolytic compounds, develops epigenetic-age biomarkers and candidate therapeutics, and offers epigenetic age testing and anti-aging product development services.
Explore TAZ Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.